Literature DB >> 32274445

Select pediatric vitreoretinal disease in the setting of Turner's syndrome.

Diana M Laura1, Nicolas A Yannuzzi1, Supalert Prakhunhungsit1,2, Audina M Berrocal1.   

Abstract

PURPOSE: To report 2 cases of pediatric vitreoretinal disease in the setting of Turner's syndrome. OBSERVATIONS: A 4-year-old girl with Turner's syndrome was referred for evaluation of a tractional retinal detachment in the right eye. Fundoscopic examination disclosed temporal dragging of the macula in the right eye, and vascular nonperfusion in the right and left eyes. Genetic testing revealed a novel frameshift mutation in the LRP5 gene consistent with familial exudative vitreoretinopathy (FEVR). The patient was treated with laser. A 14-year-old girl with Turner's syndrome presented with nyctalopia. Dilated fundus exam disclosed peri-foveal pigmentary changes and peripheral bone spicules. Full-field electroretinography demonstrated decreased rod and cone responses, consistent with retinitis pigmentosa (RP). CONCLUSIONS AND IMPORTANCE: Vitreoretinal disease, including RP and FEVR, is rarely observed in patients with Turner's syndrome.
© 2020 Published by Elsevier Inc.

Entities:  

Keywords:  Familial exudative vitreoretinopathy; Retinitis pigmentosa; Turner's syndrome

Year:  2020        PMID: 32274445      PMCID: PMC7132148          DOI: 10.1016/j.ajoc.2020.100662

Source DB:  PubMed          Journal:  Am J Ophthalmol Case Rep        ISSN: 2451-9936


Introduction

Turner's syndrome is a sex chromosome disorder caused by complete or partial loss or structural abnormality of one X chromosome, resulting in phenotypically female patients with ovarian dysgenesis and short stature. The estimated incidence is approximately one in two to three thousand live female births., Some patients are found to have somatic mosaicism, in which some cells have Karyotype 45,X and some have 46,XX. Numerous ocular findings have been reported in patients with Turners syndrome including strabismus, hypertelorism, blepharoptosis, and cataracts. Posterior segment abnormalities have been rarely reported and published accounts include patients with peripheral neovascularization (NV), Coats’ disease, morning glory disc anomaly (MGDA), retinitis pigmentosa (RP), familial exudative vitreoretinopathy (FEVR) and uniliateral and bilateral tractional retinal detachments. FEVR, first described in 1969 by Criswick and Schepens, is a rare hereditary disorder characterized by avascularity of the peripheral retina. Clinical manifestations may be variable ranging from macular dragging to retinal neovascularization, vitreous hemorrhage and tractional retinal detachment., The disorder exists in various modes of inheritance, but an autosomal dominant pattern is most common. Genes known to be associated with autosomal inheritance include FZD4, LRP5 and TSPAN12. More recently, ZNF408 was found to also play a role in the development of retinal vasculature. A missense mutation in ZNF408 resulted in abnormal retinal vasculogenesis and was found to be associated with autosomal dominant FEVR in a large Dutch family., X-linked FEVR is caused by mutations in the NDP gene – the causal gene in Norrie disease, which is an NPD-related retinopathy with overlapping features with X-linked FEVR. RP is a progressive rod-cone dystrophy characterized by a gradual increase in areas of bone spicule pigmentation in the peripheral retina, attenuation of retinal vessels, and waxy pallor of the optic disc. Patients typically suffer from nyctalopia and progressive visual field loss. RP is associated with all modes of inheritance. X-linked RP in particular accounts for 10–20% of all RP cases, and is associated with a more severe phenotype., We present two cases of patients with Turner's syndrome seen at Bascom Palmer Eye Institute—one with RP and one with FEVR—and a review of the literature.

Findings

Case 1

A 4-year-old girl with a diagnosis of Turner's syndrome (genotype 45X) was referred for evaluation of retinal detachments of both eyes. The patient was born at 40 weeks (1928 g) and had a history of hypoplastic left heart syndrome (resulting in two cardiac surgeries), recurrent urinary tract infection, and bladder reconstruction. Anterior segment examination was unremarkable. Fundoscopic examination revealed extensive peripheral retinal non-perfusion of both eyes, left more than right, with a demarcation line and neovascularization in the left eye. There was a very dense, contracted posterior hyaloid in the right eye causing dragging of the macula and disc. Spectral domain optical coherence tomography (SD-OCT) again revealed an extremely dense and contracted posterior hyaloid the right eye and a relatively normal macular contour of the left eye. Fluorescein angiography (FA) of the right and left eye revealed 360-degree peripheral retinal non-perfusion with arterial tortuosity and peripheral capillary agenesis in both eyes, and inferior and temporal late leakage seen in the left eye (Fig. 1). Laser was performed in both eyes to the peripheral avascular retina, and sub-tenon triamcinolone was subsequently injected.
Fig. 1

A four-year-old female with Turner's syndrome and Familial Exudative Vitreoretinopathy. (A) Color fundus photos of the right and left eye demonstrate a tractional contracted posterior hyaloid with dragging of the macula and disc in the right eye, and peripheral pre-retinal fibrotic membranes in both eyes. (B) Fluorescein angiography (FA) of the right and left eye display 360-degree peripheral retinal non-perfusion in both eyes, with inferior and temporal late leakage in the left eye. (C) Optical coherence tomography (OCT) of the right eye demonstrates an extremely dense and contracted posterior hyaloid. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

A four-year-old female with Turner's syndrome and Familial Exudative Vitreoretinopathy. (A) Color fundus photos of the right and left eye demonstrate a tractional contracted posterior hyaloid with dragging of the macula and disc in the right eye, and peripheral pre-retinal fibrotic membranes in both eyes. (B) Fluorescein angiography (FA) of the right and left eye display 360-degree peripheral retinal non-perfusion in both eyes, with inferior and temporal late leakage in the left eye. (C) Optical coherence tomography (OCT) of the right eye demonstrates an extremely dense and contracted posterior hyaloid. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) The patient underwent genetic testing for FEVR, and she was found to possess a novel heterozygous frameshift mutation in the LRP5 (low-density lipoprotein receptor-related protein 5) gene, c.1ldelC. She subsequently received additional laser in both eyes three times over six months. She also underwent additional sub-tenon triamcinolone injections, once in the left eye and twice in the right, over a six-month period. At 26-month follow up, the patient's Snellen best corrected visual acuity is has stabilized at 20/400 in the right eye and 20/60 in the left eye. Her dilated fundus exam is stable, and she has not required additional treatments.

Case 2

A 14-year-old girl with Turner's syndrome (mosaic genotype 46,XX/45,X) was referred to the retina service with nyctalopia. There was no known family history of retinal disease, however the patient's mother reported she has mild nyctalopia. On exam, Snellen best corrected visual acuity was 20/40 in both eyes. Anterior segment examination was unremarkable. On dilated fundus exam, there was 2+ vitreous cell, optic nerve pallor, a ring of pigmentary changes surrounding the fovea extending peripherally with bone spicules and vascular attenuation in both eyes. SD-OCT revealed outer retinal atrophy with trace cystoid changes. Fundus autofluorescence (FAF) displayed a ring of hypoautofluorescence in both eyes (Fig. 2). Full field electroretinography (ERG) revealed reduced rod and cone responses in both eyes (Fig. 3). Based on imaging results, the patient has presumed RP. The patient and family declined genetic testing.
Fig. 2

A fourteen-year-old female with Turner's syndrome and presumed Retinitis Pigmentosa. (A) Color fundus photos of the right and left eye demonstrate a ring of pigmentary changes surrounding the fovea extending peripherally with bone spicules, and vascular attenuation. (B) Optical coherence tomography (OCT) of the right and left eye display outer retinal atrophy and cystoid changes. (C) Fundus autofluorescence (FAF) of the right and left eye demonstrate a ring of hypoautofluorescence. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

Fig. 3

Full field electroretinography (ERG) of a patient with presumed Retinitis Pigmentosa. Rod, combined rod and cone, and cone ERG amplitudes are reduced in both eyes. Right eye amplitudes are more significantly reduced than left eye.

A fourteen-year-old female with Turner's syndrome and presumed Retinitis Pigmentosa. (A) Color fundus photos of the right and left eye demonstrate a ring of pigmentary changes surrounding the fovea extending peripherally with bone spicules, and vascular attenuation. (B) Optical coherence tomography (OCT) of the right and left eye display outer retinal atrophy and cystoid changes. (C) Fundus autofluorescence (FAF) of the right and left eye demonstrate a ring of hypoautofluorescence. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) Full field electroretinography (ERG) of a patient with presumed Retinitis Pigmentosa. Rod, combined rod and cone, and cone ERG amplitudes are reduced in both eyes. Right eye amplitudes are more significantly reduced than left eye.

Discussion

Several ocular findings have been reported in patients with Turner's syndrome, none of which are considered pathognomonic for the disease. Posterior segment associations vary but are generally rarely encountered. In some reports, authors have hypothesized that the ocular findings are directly related to the chromosomal abnormality, though very few have genetic testing to support this. Optic disc abnormalities have been rarely reported in Turner's syndrome. Sahni and colleagues presented a case of unilateral morning glory disc anomaly (MGDA) in an 11-year-old female with Turner's syndrome. The authors emphasized that MGDA has been reported to occur with Aicardi syndrome, another X-linked condition, and that the underlying chromosomal abnormality in Turner's was likely responsible for the changes in the optic nerve. Retinal detachment has been reported infrequently in Turner's syndrome. Khodadoust and Patron reported a unilateral retinal detachment in a 13-year-old patient with Turner's syndrome. However, it is relevant that this patient also had high myopia, and retinal detachment may have been more related to her refractive error. Another case report of a 2-month-old with Turner's syndrome described bilateral retinal detachments that resembled stage V retinopathy of prematurity (ROP) on clinical and ultrasound evaluation. The authors noted that the patient was born full term and was a normal birth weight (3000g), making ROP unlikely. They also noted that examination of family members showed no signs of FEVR, but genetic testing was not performed, and thus recessive or X-linked disease cannot be excluded. Other cases of pediatric retinal vascular disease have been reported in Turner's syndrome. Peripheral non-perfusion and neovascularization were described in two infants – one born at 34 weeks and one at 33 weeks gestation. In both patients, only one eye showed peripheral vascular abnormalities, while the fellow eyes appeared angiographically normal. Genetic testing was not performed, but the authors debated whether these cases represented ROP or FEVR. Of note, neither child had a family history of FEVR. There is another case report of a 6-year-old girl with Turner's syndrome who had exam and imaging findings suggestive of FEVR, but also did not undergo genetic testing. She presented with total retinal detachment with temporal neovascularization (confirmed with angiography) in the left eye. Examination and angiographic evaluation of family members disclosed normal fundi of the mother and three siblings, but avascular temporal retina in both eyes of the patient's father. No genetic testing was performed to confirm the mutation or to evaluate if the condition was X-liked or autosomal. All genes known to be associated with FEVR are components of the wingless (Wnt) pathway, and mutations affecting gene function result in abnormal formation of the retinal vasculature. We report the first case of FEVR in a patient with Turner's syndrome that was genetically confirmed. Our patient possesses the LPR5 gene mutation. The LPR5 gene is mapped to chromosome 11q13 in humans. In mice models, The LPR5 gene plays a role in capillary lumen formation. Mutations in this gene are inherited in either an autosomal dominant or autosomal recessive fashion. In FEVR of X-linked inheritance, NPD gene mutations are most common. Thus, in our patient, this is a rare coincidence of autosomal FEVR and Turner's syndrome. There are only 4 prior case reports of patients with concurrent Turner's syndrome and RP, with only the most recent publication containing molecular genetic confirmation. In that report, a 28-year-old female with mosaic 45,X/46,XX Turner's syndrome was found to have RP confirmed by novel mutation in the RPGR gene – the mutation accounting for approximately 80% of all X-linked retinitis pigmentosa (XLRP) cases. The authors noted that in most monosomy Turner syndrome patients, it is the paternal X chromosome that is lost. The patient's father did not carry the RPGR frameshift mutation. The authors of this report postulated that the mutant X chromosome was maternal given the mother had mild nyctalopia, though they did not have molecular genetic evidence of this. In this case, the patient's clinical presentation may have been a manifestation of an intact but mutated RPGR in the setting of lack of a normal paternal X chromosome. Prior studies indicate that affected males with the RPGR mutation exhibit a more severe phenotype, whereas carrier females are more commonly asymptomatic or have mild disease with later onset. This may explain why patients with cells with a single X chromosome and XLRP might have more severe disease. In our case, the patient and family declined genetic testing, and there was no known family history of retinal disease. The patients imaging and ERG, however, are very consistent with RP, and the patient's mother reported mild nyctalopia, similar to the case report cited above. We postulate that the patient's mother may be a carrier of the RPGR mutation with mild symptoms, and that our patient, with a single X chromosome, has XLRP with a similar clinical presentation to an affected male. These cases shed light on the possibility that patient's with Turner's syndrome are more prone to other genetic abnormalities. Numerous co-occurring X-linked conditions have been reported including Fragile X syndrome, Duchenne muscular dystrophy, and hemophilia A and B. However numerous co-occurring autosomal disorders have also been described in case reports, including Neurofibromatosis Type 1, Cornelia de Lange syndrome, Long QT syndrome, Li-Fraumeni syndrome and 17α hydroxylase deficiency. Without population based studies, it is not possible to determine if these occur at a higher rate in patients with Turner's syndrome. Interestingly, literature review reveals that aneuploidies – notably Down syndrome, and trisomy 18, 13 and 8 – appear to be more common in Turner syndrome individuals. Furthermore, these autosomal aneuploidies were largely associated with non-mosaic karyotypes, indicating a meiotic error could have lead to both disorders.

Conclusions

In conclusion, we present two cases of Turner's syndrome: one with FEVR and one with RP. To our knowledge this is the first reported genetically confirmed case of FEVR in Turner's syndrome. This is the fifth reported case of RP and Turner's syndrome.

Patient consent

Consent to publish the case report was not obtained. This report does not contain any personal information that could lead to the identification of the patient.

Funding

No funding or grant support.

Authorship

All authors attest that they meet the current ICMJE criteria for Authorship.

Declaration of competing interest

Audina M. Berrocal receives a consulting fee/honorarium from Alcon, Genentech, and ThromboGenics. The following authors have no financial disclosures: Diana M. Laura, Nicolas A. Yannuzzi, and Supalert Prakhunhungsit.
  16 in total

1.  X-linked retinitis pigmentosa.

Authors:  A C Bird
Journal:  Br J Ophthalmol       Date:  1975-04       Impact factor: 4.638

2.  Turner's syndrome associated with bilateral retinal detachments.

Authors:  J O Mason; W Tasman
Journal:  Am J Ophthalmol       Date:  1996-11       Impact factor: 5.258

3.  A rare association of familial exudative vitreoretinopathy and Turner's syndrome.

Authors:  Subrata Mandal; Pradeep Venkatesh; Neeraj Wadha; Rajpal Vohra; Saipal Garg
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2008 Sep-Oct       Impact factor: 1.402

4.  Coats' disease and turner's syndrome.

Authors:  J D Cameron; M Yanoff; W C Frayer
Journal:  Am J Ophthalmol       Date:  1974-11       Impact factor: 5.258

5.  Turner's syndrome in a male. Report of a case with myopia, retinal detachment, cataract, and glaucoma.

Authors:  A Khodadoust; D Paton
Journal:  Arch Ophthalmol       Date:  1967-05

6.  An FEVR-associated mutation in ZNF408 alters the expression of genes involved in the development of vasculature.

Authors:  Dyah W Karjosukarso; Sebastianus H C van Gestel; Jieqiong Qu; Evelyn N Kouwenhoven; Lonneke Duijkers; Alejandro Garanto; Huiqing Zhou; Rob W J Collin
Journal:  Hum Mol Genet       Date:  2018-10-15       Impact factor: 6.150

7.  Dual diagnoses in 152 patients with Turner syndrome: Knowledge of the second condition may lead to modification of treatment and/or surveillance.

Authors:  Kelly L Jones; Erin A McNamara; Mauro Longoni; Danny E Miller; Mersedeh Rohanizadegan; Laura A Newman; Frances Hayes; Lynne L Levitsky; Betty L Herrington; Angela E Lin
Journal:  Am J Med Genet A       Date:  2018-08-06       Impact factor: 2.802

8.  ZNF408 is mutated in familial exudative vitreoretinopathy and is crucial for the development of zebrafish retinal vasculature.

Authors:  Rob W J Collin; Konstantinos Nikopoulos; Margo Dona; Christian Gilissen; Alexander Hoischen; F Nienke Boonstra; James A Poulter; Hiroyuki Kondo; Wolfgang Berger; Carmel Toomes; Tomoko Tahira; Lucas R Mohn; Ellen A Blokland; Lisette Hetterschijt; Manir Ali; Johanne M Groothuismink; Lonneke Duijkers; Chris F Inglehearn; Lea Sollfrank; Tim M Strom; Eiichi Uchio; C Erik van Nouhuys; Hannie Kremer; Joris A Veltman; Erwin van Wijk; Frans P M Cremers
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

9.  Molecular Characterization of FZD4, LRP5, and TSPAN12 in Familial Exudative Vitreoretinopathy.

Authors:  Soo Hyun Seo; Young Suk Yu; Sung Wook Park; Jeong Hun Kim; Hyun Kyung Kim; Sung Im Cho; Hyunwoong Park; Seung Jun Lee; Moon-Woo Seong; Sung Sup Park; Ji Yeon Kim
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-08       Impact factor: 4.799

10.  A model for familial exudative vitreoretinopathy caused by LPR5 mutations.

Authors:  Chun-Hong Xia; Haiquan Liu; Debra Cheung; Meng Wang; Catherine Cheng; Xin Du; Bo Chang; Bruce Beutler; Xiaohua Gong
Journal:  Hum Mol Genet       Date:  2008-02-09       Impact factor: 6.150

View more
  2 in total

1.  Disorders of the eye, ear, skin, and nervous system in women with Turner syndrome -a nationwide cohort study.

Authors:  Mette Hansen Viuff; Kirstine Stochholm; Svend Juul; Claus Højbjerg Gravholt
Journal:  Eur J Hum Genet       Date:  2021-10-28       Impact factor: 4.246

2.  Pathogenic variants and associated phenotypic spectrum of TSPAN12 based on data from a large cohort.

Authors:  Wenmin Sun; Xueshan Xiao; Shiqiang Li; Xiaoyun Jia; Panfeng Wang; Qingjiong Zhang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-04-27       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.